Good Health Can’t Wait.

More documents

Recommendations

Info

Good Health Can’t Wait. Dr. Reddy’s Laboratories Limited NOTES TO FINANCIAL STATEMENTS (All amounts in Indian Rupees millions, except share data and where otherwise stated) NOTE 2: NOTES TO FINANCIAL STATEMENTS 2.1: SHARE CAPITAL PARTICULARS AS AT 31 MARCH 2015 AS AT 31 MARCH 2014 Authorised 240,000,000 (previous year: 240,000,000) equity shares of ` 5/- each 1,200 1,200 Issued 170,381,374 (previous year: 170,109,068) equity shares of ` 5/- each fully paid-up 852 851 Subscribed and fully paid-up 170,381,174 (previous year: 170,108,868) equity shares of ` 5/- each fully paid-up 852 851 Add: Forfeited share capital (e) - 852 - 851 852 851 (a) Reconciliation of the equity shares outstanding is set out below: PARTICULARS AS AT 31 MARCH 2015 NO. OF EQUITY SHARES AMOUNT AS AT 31 MARCH 2014 NO. OF EQUITY SHARES AMOUNT Number of shares outstanding at the beginning of the year 170,108,868 851 169,836,475 849 Add: Equity shares issued pursuant to employee stock option plan 272,306 1 272,393 2 Number of shares outstanding at the end of the year 170,381,174 852 170,108,868 851 (b) Terms / rights attached to equity shares The Company has only one class of equity shares having a par value of ` 5 per share. Each holder of equity shares is entitled to one vote per share. The Company declares and pays dividends in Indian rupees. During the year ended 31 March 2015, the amount of per share dividend recognized as distributions to equity shareholders is ` 20 (previous year: `18). The dividend proposed by the Board of Directors is subject to the approval of the shareholders in the ensuing Annual General Meeting. In the event of liquidation, the equity shareholders are eligible to receive the remaining assets of the Company after distribution of all preferential amounts, in proportion to their shareholding. (c) Details of shareholders holding more than 5% shares in the Company PARTICULARS AS AT 31 MARCH 2015 NO. OF EQUITY SHARES HELD % OF EQUITY SHARES HELD AS AT 31 MARCH 2014 NO. OF EQUITY SHARES HELD % OF EQUITY SHARES HELD Dr. Reddy’s Holdings Limited 39,729,284 23.32 39,729,284 23.35 First State Investments Management (UK) Limited, First State Investments International Limited and their associates* 14,389,390 8.45 14,056,799 8.26 * Does not include ADR holding. (d) 585,454 (previous year: 651,674) stock options are outstanding and are to be issued by the Company upon exercise of the same in accordance with the terms of exercise under the “Dr. Reddy’s Employees Stock Option Plan 2002” and 98,350 (previous year: 97,463) stock options are outstanding and are to be issued by the Company upon exercise of the same in accordance with the terms of exercise under the “Dr. Reddy’s Employees ADR Stock Option Plan 2007”. (Refer note 2.30) (e) Represents 200 (previous year: 200) equity shares of ` 5/- each, amount paid-up ` 500/- (rounded off in millions in the note above) forfeited due to non-payment of allotment money. 124
Standalone Financial Statements Annual Report 2014 - 15 NOTES TO FINANCIAL STATEMENTS (All amounts in Indian Rupees millions, except share data and where otherwise stated) 2.2: RESERVES AND SURPLUS PARTICULARS AS AT 31 MARCH 2015 AS AT 31 MARCH 2014 Capital reserve Balance at the beginning of the year 267 267 Movement during the year - - 267 267 Securities premium account Balance at the beginning of the year 19,157 18,815 Add: Employee stock options exercised during the year 434 342 19,591 19,157 Employee stock options outstanding* Balance at the beginning of the year 815 685 Add: Amortisation during the year, net of forfeiture 519 472 Less: Employee stock options exercised during the year (429) (342) 905 815 * Net of deferred employee stock compensation of ` 713 (previous year: ` 482) General reserve Balance at the beginning of the year 15,589 11,117 Add: Transferred from surplus 1,679 1,933 Add: Transferred from debenture redemption reserve - 2,539 17,268 15,589 Foreign currency translation reserve (a) Balance at the beginning of the year 17 373 Movement during the year (225) (356) (208) 17 Hedging reserve Balance at the beginning of the year (5) 402 Movement during the year 51 (407) 46 (5) Debenture redemption reserve Balance at the beginning of the year - 1,712 Add: Transferred from surplus - 827 Less: Transferred to general reserve - (2,539) - - Surplus Balance at the beginning of the year 56,599 43,614 Add: Current year profit 16,794 19,328 Amount available for appropriation 73,393 62,942 Less: Appropriations: Proposed dividend on equity shares 3,408 3,062 Tax on proposed dividend 694 520 Dividend of previous years 6 3 Credit of dividend distribution tax (b) (13) (2) Transferred to debenture redemption reserve - 827 Transferred to general reserve 1,679 1,933 Balance carried forward 67,619 56,599 105,488 92,439 (a) The foreign currency translation reserve comprises exchange difference on loans and advances that in substance form part of net investment in Industrias Quimicas Falcon de Mexico S.A. de C.V. (Mexico), a non-integral foreign operation as defined in AS 11 (Revised) on “The Effects of Changes in Foreign Exchange Rates”. These exchange differences will be recognised in the statement of profit and loss in the event of disposal of such net investments. (b) Credit of dividend distribution tax pertains to the availment of dividend distribution tax paid by Aurigene Discovery Technologies Limited, a subsidiary company on payment of dividend to the Company. 125
Page 1 and 2:
ANNUAL REPORT 2014-15 Good Health C
Page 3 and 4:
Our Brand We are in the business of
Page 5 and 6:
Corporate Overview Annual Report 20
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Statutory Reports • Business Resp
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Statutory Reports • Management Di
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Statutory Reports • Corporate Gov
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Statutory Reports • Additional Sh
Page 75 and 76: Statutory Reports • Additional Sh
Page 87 and 88: Statutory Reports • Board’s Rep
Page 111 and 112: Standalone Financial Statements Ann
Page 125: Standalone Financial Statements Ann
Page 165 and 166: Consolidated Financial Statements A
Page 177 and 178:
Consolidated Financial Statements A
Page 179 and 180:
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
Page 187 and 188:
Page 189 and 190:
Page 191 and 192:
Page 193 and 194:
Page 195 and 196:
Page 197 and 198:
Page 199 and 200:
Page 201 and 202:
Page 203 and 204:
Page 205 and 206:
Page 207 and 208:
Page 209 and 210:
Page 211 and 212:
Page 213 and 214:
Page 215 and 216:
Page 217 and 218:
Page 219 and 220:
Page 221 and 222:
Page 223 and 224:
Page 225 and 226:
Page 227 and 228:
Notice Annual Report 2014 - 15 NOTI
Page 229 and 230:
E-Voting Annual Report 2014 - 15 IN
Page 231:
Dr. Reddy’s Laboratories Limited
Page 235 and 236:
The future belongs, not to those wh
show all

Good Health Can’t Wait.

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?